Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
TS-021
Cat. No.:
OB0425LY-306
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
TS-021 is a selective, reversible and long-acting DPP-IV inhibitor that inhibits DPP-IV activity.
Synonyms:
667865-69-2; (2S,4S)-4-Fluoro-1-((1-hydroxy-2-methylpropan-2-yl)glycyl)pyrrolidine-2-carbonitrile benzenesulfonate; Benzenesulfonic acid (2S,4S)-4-fluoro-1-[2-[(1-hydroxy-2-methylpropan-2-yl)amino]acetyl]pyrrolidine-2-carbonitrile
CAS No.:
667865-69-2
Compound CID:
9865778
Formula:
C17H24FN3O5S
Formula Weight:
401.45
Specification
Target:
Dipeptidyl peptidase
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
TS-021 can be used for anti-hyperglycemic drug development.
